FDA device listing
Carisprodol Metabolite (Meprobamate) DAU Controls,LZI Cotinine II Controls (Urine),LZI Fentanyl Controls,LZI Methadone…
FDA device listing 1046837632 · LIN-ZHI INTERNATIONAL, INC.
Key facts
| Proprietary names | Carisprodol Metabolite (Meprobamate) DAU Controls,LZI Cotinine II Controls (Urine),LZI Fentanyl Controls,LZI Methadone II Controls (Urine),LZI Oxycodone (100) Controls (Urine),LZI Oxycodone (300) Controls (Urine),LZI Tramadol Controls (Urine),Methadone Metabolite 100 DAU Controls,Methadone Metabolite 300 DAU Controls,Norfentanyl DAU Controls |
|---|---|
| Owner/operator | LIN-ZHI INTERNATIONAL, INC. |
| Owner/operator number | 9049436 |
| Product codes | LAS |
| Device names | LAS - Drug Specific Control Materials |
| Device class | Class I |
| Classification regulations (21 CFR) | 862.3280 |
| Review panels | Clinical Toxicology |
| Registered establishments | LIN-ZHI INTERNATIONAL, INC. |
| Establishment registrations | 3003610499 |
| FEI numbers | 3003610499 |
| Establishment operations | Manufacturer |
| Registration valid through | 2026 |
At a glance
- 1–9 Registered establishments listing this device
- None listed Premarket submission listed
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA device listings
Establishments that make or process devices for the U.S. market must list each device with the FDA. A listing records the device's proprietary names, product codes and premarket submission, and every registered establishment that handles it.
Source: U.S. Food and Drug Administration (FDA), Establishment Registration and Device Listing database